Questa Madre spiega perché l’emiplegia è un affare di famiglia
https://pixabay.com/en/wheelchair-disabled-sport-active-538138/

Questa Madre spiega perché l’emiplegia è un affare di famiglia

L'emiplegia si verifica normalmente durante la gravidanza, o molto rapidamente dopo la nascita. I genitori sono fortunati ad avere alcuni momenti con il loro bambino prima che questa condizione cambia…

Continue Reading Questa Madre spiega perché l’emiplegia è un affare di famiglia
Cette mère explique pourquoi l’hémiplégie est une affaire familiale
https://pixabay.com/en/wheelchair-disabled-sport-active-538138/

Cette mère explique pourquoi l’hémiplégie est une affaire familiale

L'hémiplégie se produit normalement pendant la grossesse, ou très rapidement après la naissance. Les parents ont de la chance d'avoir quelques instants avec leur enfant avant que cette condition ne…

Continue Reading Cette mère explique pourquoi l’hémiplégie est une affaire familiale
Des nouveaux traitements estivaux sont en cours pour les patients atteints de SLA
https://pixabay.com/en/syringe-pill-capsule-morphine-1884784/

Des nouveaux traitements estivaux sont en cours pour les patients atteints de SLA

Je suis sûr que vous avez entendu parler de la SLA après que le «Défi du dégel de glace» ait balayé la nation en 2014, mais peu ont probablement pris…

Continue Reading Des nouveaux traitements estivaux sont en cours pour les patients atteints de SLA

Los enfermos de fibrosis quística del Reino Unido están luchando duramente por Orkambi: aquí está cómo usted puede ayudar

Orkambi (ivacaftor / lumacaftor) es la segunda medicina de precisión con licencia para uso en el Reino Unido por personas con fibrosis quística. ¿La captura? Actualmente no es proporcionado por…

Continue Reading Los enfermos de fibrosis quística del Reino Unido están luchando duramente por Orkambi: aquí está cómo usted puede ayudar

Les victimes britanniques de la fibrose kystique se battent pour Orkambi: voici comment vous pouvez vous aider

Orkambi (ivacaftor / lumacaftor) est le second médicament de précision à être autorisé à être utilisé au Royaume-Uni par des personnes atteintes de fibrose kystique. La prise? Il n'est actuellement…

Continue Reading Les victimes britanniques de la fibrose kystique se battent pour Orkambi: voici comment vous pouvez vous aider
All Eyes are Open for This New Narcolepsy Drug
Source: https://pixabay.com/en/person-profile-portrait-senior-1615692/

All Eyes are Open for This New Narcolepsy Drug

At a recent conference, Jazz Pharmaceuticals presented positive efficacy results from the JZP-110 (TONES) studies in adult patients with sleep impairment conditions and the excessive sleepiness associated with these diseases.…

Continue Reading All Eyes are Open for This New Narcolepsy Drug
World Hemophilia Day Ignites Hemophilia Awareness and Explodes with Inspiration
https://pixabay.com/en/sparkler-holding-hands-firework-677774/

World Hemophilia Day Ignites Hemophilia Awareness and Explodes with Inspiration

I came across an interesting blog about World Hemophilia Day (WHD) which was April 17th, 2017. It’s an interesting read, and fairly simple, one every woman should know about for inspiration,…

Continue Reading World Hemophilia Day Ignites Hemophilia Awareness and Explodes with Inspiration
This Drug Would Target the Heart of Genetic Obesity
Source: https://pixabay.com/en/horizontal-bathroom-scale-weight-162952/

This Drug Would Target the Heart of Genetic Obesity

Rhythm Pharmaceuticals is currently developing a melanocrotin-4 (MC4) receptor therapy called setmelanotide for the treatment of obesity and related disorders caused by genetic defects. This therapy could potentially be used to…

Continue Reading This Drug Would Target the Heart of Genetic Obesity
This Just In! Promising Results from Ulcerative Colitis Clinical Trial!
Source: https://pixabay.com/en/newspaper-newspaper-delivery-mailbox-1746350/

This Just In! Promising Results from Ulcerative Colitis Clinical Trial!

The highly-anticipated data from Pfizer's Phase 3 Octave Studies of tofacitinib in ulcerative colitis patients were published early last month in The New England Journal of Medicine. The data overall…

Continue Reading This Just In! Promising Results from Ulcerative Colitis Clinical Trial!
This Drug May Reduce Your Dependence on Transfusions
Source: https://pixabay.com/en/blood-medical-attempts-tube-1291132/

This Drug May Reduce Your Dependence on Transfusions

Celgene Corporation, partnered with Acceleron Pharma Inc., announced at the beginning of this month that target enrollment of myelodysplastic syndromes (MDS) and beta thalassemia patients for the MEDALIST and BELIEVE…

Continue Reading This Drug May Reduce Your Dependence on Transfusions